| Natera, Inc. Common Stock | $32.0b | $262.87 | -0.4% | 183.9K | |
| Illumina Inc | $24.7b | $177.21 | +0.2% | 133.4K | |
| Labcorp Holdings Inc. | $21.3b | $268.35 | +0.8% | 33.6K | |
| QIAGEN N.V. | $7.5b | $38.86 | -0.1% | 150.0K | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $110.76 | -0.7% | 63.8K | |
| Veracyte, Inc. | $3.7b | $59.00 | +0.0% | 87.6K | |
| 10x Genomics, Inc. Class A Common Stock | $3.6b | $35.82 | +0.2% | 135.3K | |
| GeneDx Holdings Corp. Class A Common Stock | $1.5b | $69.08 | +0.8% | 48.8K | |
| NeoGenomics, Inc. | $1.4b | $13.70 | +0.5% | 150.2K | |
| Personalis, Inc. Common Stock | $1.2b | $12.93 | +0.4% | 351.3K | |
| CareDx, Inc. | $1.2b | $28.44 | +1.4% | 60.5K | |
| Opko Health Inc. | $1.1b | $1.58 | +4.3% | 712.6K | |
| Azenta, Inc. | $1.1b | $24.84 | +0.4% | 33.5K | |
| Mesa Laboratories Inc | $0.6b | $99.49 | 0.0% | 8.4K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.48 | 0.0% | 9.0K | |
| Pacific Biosciences of California, Inc. | $462.8m | $1.63 | +1.3% | 910.7K | |
| Myriad Genetics Inc | $375.0m | $5.54 | +1.9% | 89.8K | |
| Prenetics Global Limited Class A Ordinary Share | $358.7m | $19.57 | -2.7% | 9.9K | |
| Insight Molecular Diagnostics Inc. Common Stock | $200.5m | $5.59 | +2.0% | 7.5K | |
| ALPS Group Inc Ordinary Share | $126.4m | $0.61 | 0.0% | 6.3K | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $1.73 | +20.0% | 43.5M | |
| Bionano Genomics, Inc. Common Stock | $14.2m | $1.14 | 0.0% | 40.9K | |
| BioNexus Gene Lab Corp Common stock | $5.6m | $2.08 | 0.0% | 297 |